Brendan Bulik-Sullivan is a partner at GV where he focuses on life sciences investments.
Prior to GV, Brendan’s career focused on applied statistics and machine learning research in genetics and biotechnology. He designed machine learning models for personalized immuno-oncology therapeutics at Gritstone Oncology and developed methods for statistical genetics research at the Broad Institute. Brendan’s work has been published in high-profile journals including Nature, Science, Nature Biotechnology and Nature Genetics.
Brendan has a B.A. in mathematics from the University of California, Berkeley and Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.